Recomendaciones sobre influenza en niños

Referencias bibliográficas:

1. Lessin HR, Edwards KM; Committee on Practice and Ambulatory Medicine; Committee on Infectious Diseases. Immunizing parents and other close family contacts in the pediatric office setting. Pediatrics. 2012; 129(1). Available at: www. pediatrics. org/ cgi/content/ full/ 129/ 1/ e247

2. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: Influenza

immunization for all health care personnel: keep it mandatory. Pediatrics. 2015; 136(4):809–818

3. American Academy of Pediatrics Committee on Pediatric Emergency Medicine. Preparation for emergencies in the offices of pediatricians and pediatric primary care providers. Pediatrics. 2007; 120(1):200–212. Reaffirmed June 2011

Recursos adicionales:

American Academy of Pediatrics Committee on Pediatric Emergency Medicine; American Academy of Pediatrics Committee on Medical Liability; Task Force on Terrorism. The pediatrician and disaster preparedness. Pediatrics. 2006; 117(2):560–565. Reaffirmed September 2013

American Academy of Pediatrics. Influenza. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:476–493. Available at: http:// aapredbook. aappublications.org/ flu

Chan-Tack KM, Kim C, Moruf A, Birnkrant DB. Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014). Antivir Ther. 2015; 20(5):561–564 Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2015–2016. Pediatrics. 2015; 136(4):792–808

Des Roches A, Paradis L, Gagnon R, et al; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network. Egg allergic patients can be safely vaccinated against influenza. J Allergy Clin Immunol. 2012; 130(5):1213–1216.e1

Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 2005; 115(4):1039–1047

Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM; Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza— recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011; 60(1 RR-1):1–24

Frey SE, Reyes MR, Reynales H, et al. Comparison of the safety and immunogenicity of an MF59®- adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 2014; 32(39):5027–5034

Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2016-17 influenza season. MMWR Morb Mortal Wkly Rep. 2016; 65(RR-3):1–54

Haber P, Moro PL, Cano M, et al. Postlicensure surveillance of trivalent live-attenuated influenza vaccine in children aged 2–18 years, Vaccine Adverse Event Reporting System, United States, July 2005–June 2012. J Pediatric Infect Dis Soc. 2015; 4(3):205–213